Status:
COMPLETED
CGM Use in Children With Type 2 Diabetes
Lead Sponsor:
Johns Hopkins University
Conditions:
Type 2 Diabetes
Hyperglycemia Due to Type 2 Diabetes Mellitus
Eligibility:
All Genders
5-21 years
Phase:
NA
Brief Summary
The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for a 10 day wear period in pediatric Type 2 diabetes patients improves short term time in range glucose co...
Detailed Description
The purpose of this prospective study is to determine if trial use of a Dexcom G6 CGM system for 10 days has an impact on short and long term glycemic control and behavior in youth onset Type 2 diabet...
Eligibility Criteria
Inclusion
- Type 2 diabetes, diabetes duration \>3 months
Exclusion
- Prior use of CGM
Key Trial Info
Start Date :
January 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 28 2022
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT04721158
Start Date
January 17 2021
End Date
July 28 2022
Last Update
September 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Pediatric Diabetes Center
Baltimore, Maryland, United States, 21287